This inventor holds 1 USPTO granted patent. Top assignee: Novo Nordisk A/s. Active years: 1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999
Title: Tina Mo Tagmose: Innovator in Pharmaceutical Chemistry
Introduction
Tina Mo Tagmose is a distinguished inventor based in Farum, Denmark. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target various diseases.
Latest Patents
Tina holds a patent for "Fused 1,2,4-thiadiazine and fused 1,4-thiazine derivatives." This patent describes compounds represented by a specific formula, wherein A, B, D, R¹, R², R³, and R⁴ are defined in the description. The compounds are noted for their potential utility in treating diseases affecting the central nervous system, cardiovascular system, pulmonary system, gastrointestinal system, and endocrinologic system.
Career Highlights
Tina is currently employed at Novo Nordisk A/S, a leading global healthcare company. Her work focuses on innovative solutions in the pharmaceutical industry, contributing to advancements in medical treatments.
Collaborations
Throughout her career, Tina has collaborated with notable colleagues, including Flemming E Nielsen and Holger C Hansen. These partnerships have fostered a collaborative environment that enhances research and development efforts.
Conclusion
Tina Mo Tagmose exemplifies the spirit of innovation in pharmaceutical chemistry. Her contributions through patents and collaborations continue to impact the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile